EGFR/IL13Rα2 Pool-CAR T Cells

· City of Hope Medical Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EGFR/IL13Rα2 Pool-CAR T Cells, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas [Phase 1]

See pricing